enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bladder Cancer and Medicare: What’s Covered and What’s Not?

   www.aol.com/bladder-cancer-medicare-covered-not...

   Tips for managing expenses for bladder cancer treatment. Several factors affect the cost of treating bladder cancer, including: how aggressive the cancer is. the stage at which it was diagnosed.

3. Bladder cancer - Wikipedia

   en.wikipedia.org/wiki/Bladder_cancer

   Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2] This makes bladder cancer the sixth most common cancer in men, and the seventeenth in women. [58] When women are diagnosed with bladder cancer, they tend to have more advanced disease and consequently a poorer prognosis. [58]

4. Pfizer's bladder cancer therapy meets main goal in late-stage ...

   www.aol.com/pfizers-bladder-cancer-therapy-meets...

   The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...

5. Gemcitabine - Wikipedia

   en.wikipedia.org/wiki/Gemcitabine

   Gemcitabine, sold under the brand name Gemzar, among others, [1] is a chemotherapy medication used to treat cancers. [2] It is used to treat testicular cancer, [3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.

6. Lower urinary tract symptoms - Wikipedia

   en.wikipedia.org/wiki/Lower_urinary_tract_symptoms

   Surgical treatment of LUTS can include: Ablation procedures – used in treating both bladder tumours [22] and bladder outlet obstruction, such as prostate conditions. [23] Bladder-neck incision (BNI) Removal of the prostate – open, robotic, and endoscopic techniques are used. Stenting of the prostate [24] and urethra.

7. The Latest Breakthroughs That Could Help Bladder Cancer ... - AOL

   www.aol.com/news/latest-breakthroughs-could-help...

   For the next 40 years, Coley and his research collaborators would test similar remedies on more than 1,000 cancer patients. Today, Coley is sometimes called the father of immunotherapy, which is a ...